A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.
A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
Researchers from Aarhus University have identified why the gene APOE4 carries a significantly higher risk of developing ...
SurvivorNet on MSN
Powerful New Evidence Finds CDK4/6 Inhibitors Reduce Recurrence Risk In The Largest Sub-Group of Breast Cancer Patients
New research presented this year highlighted major advances for people with hormone-receptor–positive, HER2-negative breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback